US OTC legislation moves closer


Legislation to regulate the over-the-counter derivatives market took its first steps through the US Congress last month, with two House committees passing versions of a US Treasury bill submitted in August.

The two proposals must now be reconciled and pass a vote by the entire House. A third bill was introduced in the Senate in September by Jack Reed, chairman of the Subcommittee on Securities, Insurance, and Investment, but has not started to move forward through the committee stage to a debate

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

If you already have an account, please sign in here.


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here